Laurel Pharmaceuticals Pvt Ltd
About Laurel Pharmaceuticals Pvt Ltd
Data last updated:
Laurel Pharmaceuticals Pvt Ltd is a private limited company based in Jalandhar, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 July 1981 and has been in existence for over 45 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB1981PTC004609. Its GSTIN is 03AADCM3292N1ZA (Punjab).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.5 Lakh. It is led by directors including Udit Nanda and Ajay Nanda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 57 Focal Point Extension, Jalandhar, Punjab, India – 144001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.91 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹3.74 Lakh (net margin 2%) and EBITDA of ₹12.33 Lakh (EBITDA margin 6.5%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 6% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹25.52 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressE – 57 Focal Point Extension, Jalandhar, Punjab, India – 144001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Laurel Pharmaceuticals Pvt Ltd
The main business activity of Laurel Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Laurel Pharmaceuticals Pvt Ltd FY 2025 filings available
Laurel Pharmaceuticals Pvt Ltd reported revenue of ₹1.91 Cr (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Laurel Pharmaceuticals Pvt Ltd
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Laurel Pharmaceuticals Pvt Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹12.33 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.74 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Laurel Pharmaceuticals Pvt Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Laurel Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Laurel Pharmaceuticals Pvt Ltd
Laurel Pharmaceuticals Pvt Ltd is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Phenomenon Nutritech Private Limited | ₹1.91 Cr (FY 2025) | •••• | •••• | 399.0% | •••• | Ahmedabad, Gujarat, India |
| Zenith Chemical Works Private Limited | ₹1.91 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Mumbai, Maharashtra, India |
| Rege Engredea Private Limited | ₹1.91 Cr (FY 2018) | •••• | •••• | •••• | Nalgonda, Telangana, India | |
| Markwell Pharmaceuticals Private Limited | ₹1.91 Cr (FY 2024) | •••• | •••• | -1.0% | •••• | Agra, Uttar Pradesh, India |
| Kan India Realtors Private Limited | ₹1.91 Cr (FY 2025) | •••• | •••• | 81.0% | •••• | Thane, Maharashtra, India |
| Laurel Pharmaceuticals Pvt Ltd this company | ₹1.91 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Jalandhar, Punjab, India |
| White Maple Pharmaceuticals Private Limited | ₹1.9 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Dibrugarh, Assam, India |
| Avosia Pharma Private Limited | ₹1.9 Cr (FY 2025) | •••• | •••• | 247.0% | •••• | Bathinda, Punjab, India |
| Morksons Pharmaceuticals (India) Private Limited | ₹1.9 Cr (FY 2020) | •••• | •••• | -51.0% | •••• | New Delhi, Delhi, India |
| Zenkins Pharmaceuticals Private Limited | ₹1.9 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Ambala Cantt, Haryana, India |
| Morningg Life Pharmaceuticals Private Limited | ₹1.89 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Varanasi, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Laurel Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Laurel Pharmaceuticals Pvt Ltd
Laurel Pharmaceuticals Pvt Ltd is audited by ARUN MALHOTRA & CO for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ARUN MALHOTRA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Laurel Pharmaceuticals Pvt Ltd
Laurel Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Udit Nanda | Director | 27 Jul 2010 | 16 Years 2 Months | Current |
| Ajay Nanda | Director | 25 Aug 1982 | 44 Years 1 Months | Current |
| Sunita Nanda | Director | 27 Jul 2010 | 16 Years 2 Months | Current |
Ownership and Shareholding of Laurel Pharmaceuticals Pvt Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Laurel Pharmaceuticals Pvt Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Feb 2018 | Others | ₹6 Lakh | Open |
| 09 May 2011 | Canara Bank | ₹1.08 Lakh | Open |
| 11 Dec 1996 | Canara Bank | ₹3.18 Lakh | Open |
| 23 Jan 1990 | Canara Bank | ₹2.49 Lakh | Open |
| 12 Sep 1988 | Canara Bank | ₹4.77 Lakh | Open |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Laurel Pharmaceuticals Pvt Ltd
Laurel Pharmaceuticals Pvt Ltd has a workforce of 3 employees as of Feb 25, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Laurel Pharmaceuticals Pvt Ltd
Laurel Pharmaceuticals Pvt Ltd has 9 board changes on record since 1982: 3 appointments and 6 cessations. The latest: Sunita Nanda ceased to be Additional Director on 30 Sep 2015.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Laurel Pharmaceuticals Pvt Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Laurel Pharmaceuticals Pvt Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Laurel Pharmaceuticals Pvt Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Laurel Pharmaceuticals Pvt Ltd
Laurel Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AADCM3292N1ZA | Punjab | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Laurel Pharmaceuticals Pvt Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Laurel Pharmaceuticals Pvt Ltd
Laurel Pharmaceuticals is an active private limited company based in Jalandhar, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 July 1981 (45+ years old) and is registered under CIN U24232PB1981PTC004609.
Laurel Pharmaceuticals reported revenue of ₹1.91 Cr for FY 2025 (down 7% YoY).
Laurel Pharmaceuticals has 3 current directors:
- Udit Nanda - Director
- Ajay Nanda - Director
- Sunita Nanda - Director
Laurel Pharmaceuticals reported a net profit of ₹3.74 Lakh (net margin 2%) and EBITDA of ₹12.33 Lakh (EBITDA margin 6.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Laurel Pharmaceuticals is -6% over three years and 6% over five years. In the latest year (FY 2025) revenue fell 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Laurel Pharmaceuticals is 03AADCM3292N1ZA, registered in Punjab.
The CIN (Corporate Identification Number) of Laurel Pharmaceuticals is U24232PB1981PTC004609. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Laurel Pharmaceuticals was incorporated on 10 July 1981, making it 45+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Laurel Pharmaceuticals by revenue are Phenomenon Nutritech Private Limited, Zenith Chemical Works Private Limited, Rege Engredea Private Limited, Markwell Pharmaceuticals Private Limited, Kan India Realtors Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Sunita Nanda ceased to be Additional Director on 30 Sep 2015. Udit Nanda ceased to be Additional Director on 30 Sep 2015. Bhushan Nanda ceased to be Director on 08 Aug 2012. Laurel Pharmaceuticals has 9 board changes on record in total.
The registered office of Laurel Pharmaceuticals is at E – 57 Focal Point Extension, Jalandhar, Punjab, India – 144001.